Endoscopic treatment of airway stenosis after lung transplantation  by Anile, Marco et al.
Our current strategy is to ‘‘perfuse
and watch’’ with the aid of real-time
monitoring and diagnostic imaging.
As Rescigno and colleagues mentioned,
near-infrared spectroscopy (NIRS) is
useful for detecting newly developed
cerebral malperfusion. Although they
recognized an undesirable situation by
inflow pressure and NIRS data, the for-
mer may not be apparent if the intima
breaks at the suture line and pressure el-
evation is not apparent. Decreased oxy-
gen saturation is likely to be a reliable
indicator of an occurrence of something
undesirable, whatever the cause.
Once malperfusion is detected, it is
necessary to develop an appropriate
strategy for restoring cerebral perfusion
based on the cause of malperfusion.
In this regard, visualization of the
‘‘Y-junction’’ with transesophageal
echocardiography can be helpful for
correctly pursuing the strategy, because
it provides real-time information on
morphology and perfusion.
However, the decision can be incor-
rect, as in our case. Thus, the decision
needs to be immediately assessed to
avoid further delay in restoring ade-
quate perfusion. This can be achieved
by NIRS. If oxygen saturation remains
low, other possible scenarios should be
considered.
We believe that a sequence of ‘‘de-
tection, decision, assessment’’ is impor-
tant in the operating room, especially in
cases of acute aortic dissection. To min-
imize ‘‘unfortunate events of unknown
cause,’’ it is necessary to fully use the
modalities available for obtaining real-
time information. This will be another
important task for cardiovascular sur-
geons, as well as surgical skill.
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Reply to the Editor:
We appreciate the interest that Drs
Anile and Ventura have in the manage-
ment of lung transplant recipients with
distal focal bronchial stenosis (type 3
disease) and diffuse distal stenosis
(type 4 disease). This is a complex
group of patients to manage, and their
airway issues can be challenging.1
As a high-volume center for bron-
chial stent placement (for causes other
than transplantation), we have been
uniformly disappointed with the use
of expandable metallic stents. Metallic
stents in the airway are expensive and
associated with fracture, overgrowth
of granulation tissue, and erosion
through the tracheobronchial wall.
Although the cost of a single metallic
stent is low in comparison with the
total expense of lung transplantation,
cost precludes having a large inventory
of these stents available. We currently
have an inventory of more than 100 Si-
lastic stents (Hood Laboratories, Pem-
broke, Mass, and Bryan Corporation,
Woburn, Mass). This inventory allows
us to find the right stent for almost any
airway, to tailor a specific stent to an
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To the Editor:
We read with interest the article
from Thistlethwaite and colleagues1
entitled ‘‘Airway stenoses after lung
transplantation: incidence, manage-
ment and outcome.’’
We agree that silicone stents are ex-
tremely useful to complete treatment
of posttransplantation airway stenosis
after mechanical/laser debridement;
they can effectively support the airway
during healing and prevent recurrence.
The use of this type of stent is particu-
larly indicated for type 1 and 2 stenosis
(according to the classification reported
by the authors), and they can be easily
fenestrated to allow ventilation to the
upper lobes when the bronchial stenosis
comes across them. However, we have
met some difficulties in placing these
stents when the stenosis is extremely
long and tortuous, encompassing also
the airway distal to the anastomosis for
a long segment or the peripheral airway
(type 3 and 4 stenosis). This is obvi-
ously a very small group of patients
(in the reported series there are only 3
[15%] patients), but this problem has
been certainly met by all the groups per-
forming lung transplantation, and the
difficulties in its treatment are evident.
When this type of complication occurs,
it usually requires several treatments
with unsatisfactory results, and perma-
nent stenting is usually indicated. In
this situation we have found extremely
useful the use of covered expandable
metallic stents (Ultraflex; Boston
Scientific, Galway, Ireland). They can
be easily deployed, completing airway
dilatation, and present a better ratio be-
tween the thickness of the wall of the
stent and the diameter of the stent itself,d Cardiovascular Surgery c July 2009allowing a better airflow, especially for
small diameters; thus clearance of se-
cretion is improved. Although they are
more expensive than silicone stents
and clearly more difficult to remove,
their use might be preferred in this sub-
set of patients. We have used them in 5
patients without major complications.
Could the authors provide more de-
tails about the group of patients with
type 3 and 4 stenosis?
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